DiaMedica Therapeutics Inc. Operating Lease Cost
DiaMedica Therapeutics Inc. (DMAC) reported Operating Lease Cost of $52.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-10
- DiaMedica Therapeutics Inc. operating lease, cost for the quarter ending 2026-06-30 was $26.00K, a 0.00% change year-over-year.
- DiaMedica Therapeutics Inc. operating lease, cost for the quarter ending 2026-03-31 was $26.00K, a 0.00% change year-over-year.
- DiaMedica Therapeutics Inc. operating lease, cost for the quarter ending 2025-12-31 was -$52.00K, a 300.00% decline year-over-year.
- DiaMedica Therapeutics Inc. operating lease, cost for the quarter ending 2025-09-30 was $26.00K, a 0.00% change year-over-year.
- DiaMedica Therapeutics Inc. operating lease, cost for fiscal 2024 was $104.00K, a 0.00% change from fiscal 2023.
- DiaMedica Therapeutics Inc. operating lease, cost for fiscal 2023 was $104.00K, a 33.33% increase from fiscal 2022.
- DiaMedica Therapeutics Inc. operating lease, cost for fiscal 2022 was $78.00K, a 20.00% increase from fiscal 2021.
- DiaMedica Therapeutics Inc. operating lease, cost for fiscal 2021 was $65.00K, a 1.52% decline from fiscal 2020.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $52.00K 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $26.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $26.00K 10-Q · filed 2026-05-06 | -$26.00K derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $26.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$52.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-06 | -$26.00K derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $26.00K 10-Q · filed 2026-05-06 | $104.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $52.00K derived: sum of 2 quarters · filed 2026-08-10 | $78.00K 10-Q · filed 2025-11-12 | $104.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $52.00K 10-Q · filed 2026-08-10 | $78.00K derived: sum of 3 quarters · filed 2026-08-10 | $104.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $26.00K 10-Q · filed 2025-05-13 | $52.00K derived: sum of 2 quarters · filed 2026-03-30 | $78.00K derived: sum of 3 quarters · filed 2026-03-30 | $104.00K derived: sum of 4 quarters · filed 2026-03-30 | |
| 2024-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $52.00K derived: sum of 2 quarters · filed 2026-03-30 | $78.00K derived: sum of 3 quarters · filed 2026-03-30 | $104.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $52.00K derived: sum of 2 quarters · filed 2025-11-12 | $78.00K 10-Q · filed 2025-11-12 | $104.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $52.00K 10-Q · filed 2025-08-12 | $78.00K derived: sum of 3 quarters · filed 2025-08-12 | $104.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $26.00K 10-Q · filed 2025-05-13 | $52.00K derived: sum of 2 quarters · filed 2025-05-13 | $78.00K derived: sum of 3 quarters · filed 2025-05-13 | $104.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $52.00K derived: sum of 2 quarters · filed 2025-03-17 | $78.00K derived: sum of 3 quarters · filed 2025-03-17 | $104.00K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $52.00K derived: sum of 2 quarters · filed 2024-11-13 | $78.00K 10-Q · filed 2024-11-13 | $104.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $52.00K 10-Q · filed 2024-08-07 | $78.00K derived: sum of 3 quarters · filed 2024-08-07 | $98.00K derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | $26.00K 10-Q · filed 2024-05-08 | $52.00K derived: sum of 2 quarters · filed 2024-05-08 | $72.00K derived: sum of 3 quarters · filed 2024-05-08 | $88.00K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $46.00K derived: sum of 2 quarters · filed 2024-03-19 | $62.00K derived: sum of 3 quarters · filed 2024-03-19 | $78.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $36.00K derived: sum of 2 quarters · filed 2023-11-13 | $52.00K 10-Q · filed 2023-11-13 | $68.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $32.00K 10-Q · filed 2023-08-14 | $48.00K derived: sum of 3 quarters · filed 2023-08-14 | $63.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-15 | $32.00K derived: sum of 2 quarters · filed 2023-05-15 | $47.00K derived: sum of 3 quarters · filed 2023-05-15 | $64.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $31.00K derived: sum of 2 quarters · filed 2023-03-28 | $48.00K derived: sum of 3 quarters · filed 2023-03-28 | $65.00K 10-K · filed 2023-03-28 | |
| 2021-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $32.00K derived: sum of 2 quarters · filed 2021-11-10 | $49.00K 10-Q · filed 2021-11-10 | $66.00K derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $34.00K 10-Q · filed 2021-08-11 | $51.00K derived: sum of 3 quarters · filed 2022-03-14 | $68.00K derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-03-31 | $17.00K 10-Q · filed 2021-05-05 | $34.00K derived: sum of 2 quarters · filed 2022-03-14 | $51.00K derived: sum of 3 quarters · filed 2022-03-14 | $67.00K derived: sum of 4 quarters · filed 2022-03-14 | |
| 2020-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $34.00K derived: sum of 2 quarters · filed 2022-03-14 | $50.00K derived: sum of 3 quarters · filed 2022-03-14 | $66.00K 10-K · filed 2022-03-14 | |
| 2020-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $33.00K derived: sum of 2 quarters · filed 2020-11-04 | $49.00K 10-Q · filed 2020-11-04 | $65.00K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2020-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $32.00K 10-Q · filed 2020-08-11 | $48.00K derived: sum of 3 quarters · filed 2020-08-11 | $65.00K derived: sum of 4 quarters · filed 2020-08-11 | |
| 2020-03-31 | $16.00K 10-Q · filed 2020-05-13 | $32.00K derived: sum of 2 quarters · filed 2020-05-13 | $49.00K derived: sum of 3 quarters · filed 2020-05-13 | $65.00K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2019-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $33.00K derived: sum of 2 quarters · filed 2020-03-23 | $49.00K derived: sum of 3 quarters · filed 2020-03-23 | $65.00K 10-K · filed 2020-03-23 | |
| 2019-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $33.00K derived: sum of 2 quarters · filed 2019-11-13 | $49.00K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $32.00K 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |